Evaluation of presepsin as a diagnostic tool in newborns with risk of early-onset neonatal sepsis

OBJECTIVES: To evaluate the efficacy of presepsin (P-SEP) as a potential biomarker of early-onset neonatal sepsis (EOS) and compare it to other routinely used markers of inflammation. To establish the cut-off values of P-SEP for EOS. STUDY DESIGN: 184 newborns were prospectively recruited between Ja...

Descripción completa

Detalles Bibliográficos
Autores principales: Pospisilova, Iva, Brodska, Helena L., Bloomfield, Marketa, Borecka, Klara, Janota, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869960/
https://www.ncbi.nlm.nih.gov/pubmed/36699313
http://dx.doi.org/10.3389/fped.2022.1019825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869960/
https://www.ncbi.nlm.nih.gov/pubmed/36699313
http://dx.doi.org/10.3389/fped.2022.1019825

Ejemplares similares